• Neurosterix Pharma Sàrl

    GE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-660.1.119.024-3
    Sector: Research and development

    Age of the company

    1 Year

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    20'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Neurosterix Pharma Sàrl

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Neurosterix Pharma Sàrl

    • Neurosterix Pharma Sàrl has its legal headquarters in Genève and is active. It operates in the sector «Research and development».
    • The management has 7 active persons registered.
    • All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 03.06.2025.
    • In the commercial register the company Neurosterix Pharma Sàrl is registered under the UID CHE-330.853.813.
    • Ability Neurotech SA, Aleos Bio SA, BrainQuant SA are registered at the same address.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    La recherche, le développement, la production, la fabrication et la commercialisation de produits pharmaceutiques, biologiques ou analogues. La Société peut également en Suisse et à l'étranger: créer des succursales ou des filiales, prendre des intérêts et, plus généralement, participer à toute entreprise similaire; faire, pour son propre compte ou pour le compte de tiers, toutes autres opérations financières, commerciales, mobilières ou immobilières se rapportant directement ou indirectement à son but ou jugées propres à le favoriser; et prêter de l'argent ou accorder des garanties aux associés ou à des tiers, à condition que cela serve les intérêts de la Société.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    BDO SA
    Vernier 23.12.2024

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Neurosterix Pharma LLC
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Neurosterix Pharma Sàrl

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250603/2025 - 03.06.2025
    Categories: Change in management

    Publication number: HR02-1006347581, Commercial Registry Office Geneva, (660)

    Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 23.12.2024, p. 0/1006214249). Dyer Timothy n'est plus gérant;
    ses pouvoirs sont radiés. Callori Frederick, des USA, à Marblehead, USA, est gérant unique avec signature individuelle. Signature individuelle a été conférée à Dommer Nicolas Simon, de Bütschwil-Ganterschwil, à Bâle

    SOGC 241223/2024 - 23.12.2024
    Categories: Change of auditors

    Publication number: HR02-1006214249, Commercial Registry Office Geneva, (660)

    Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 23.08.2024, p. 0/1006113460). Radiation de la mention relative à la renonciation à un contrôle restreint.

    Organe de révision:
    BDO SA (CHE-398.161.059), succursale à Vernier.

    SOGC 240823/2024 - 23.08.2024
    Categories: Change in management

    Publication number: HR02-1006113460, Commercial Registry Office Geneva, (660)

    Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 13.05.2024, p. 0/1006030830). Signature collective à deux a été conférée à Kalinichev Mikhail, de France, à Annecy, FRA, directeur, Lütjens Robert Johannes, de Coppet, à Nyon, directeur, Rocher Jean-Philippe François Christian, de France, à Vétraz-Monthoux, FRA, directeur, et Thoulouze ép. Ancey Nathalie Céline, de France, à La Tour, FRA, directrice.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm